Financials
- Market Capitalization 153.7 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.03
Fiyat/satışlar oranı
47.35
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3740 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | -1.43% | -5.48% | -38.39% | 154.72 M USD | ||
| 3745 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -8.06% | -36.67% | -40.00% | 151.90 M USD | ||
| 3752 | EQ Equillium, Inc. - Common Stock | 2.39 USD | -2.45% | +4.37% | +4.37% | +43.11% | 151.55 M USD | ||
| 3767 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.27 USD | -4.18% | -6.56% | +10.71% | -19.05% | 146.80 M USD |